TY  - RPRT
TI  - Development of highly potent neutralising nanobodies against multiple SARS-CoV-2 variants including the variant of concern B.1.351
AU  - Sziemel, A. M.
AU  - Hwa, S.-H.
AU  - Sigal, A.
AU  - Tyson, G.
AU  - Logan, N.
AU  - Willett, B. J.
AU  - Durcan, P. J.
PY  - 2021
DO  - 10.1101/2021.04.11.439360
UR  - https://www.biorxiv.org/content/10.1101/2021.04.11.439360v1
ID  - 10.1101/2021.04.11.439360
ER  -